- Scrip Originals
Entasis nets $70mm via IPO
Antibiotics developer Entasis Therapeutics Holdings Inc. netted $69.75mm in its initial public offering of 5mm common shares priced at $15. The company had planned to sell 4.4mm shares between $16 and $18 each.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com